4 Undervalued Health Care Equipment & Supplies Stocks for Tuesday, October 29
Discover the top 4 undervalued Health Care Equipment & Supplies stocks for Tuesday, October 29 based on AAII’s Stock Grades.Tudor Pop
Stock Evaluator: Aethlon Medical, Inc. (AEMD)
Aethlon Medical, Inc. AEMD
$5.75
-0.05
-0.86%
November 4, 2026 4:00:01 PM
EST
Volume: 15,809
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.
Commentary & Analysis
3 Undervalued Advanced Medical Equipment & Technology Stocks for Thursday, September 12
Discover the top 3 undervalued Advanced Medical Equipment & Technology stocks for Thursday, September 12 based on AAII’s Stock Grades.Eunice Kim
3 Undervalued Advanced Medical Equipment & Technology Stocks for Thursday, June 13
Discover the top 3 undervalued Advanced Medical Equipment & Technology stocks for Thursday, June 13 based on AAII’s Stock Grades.Grace Malone
4 Undervalued Advanced Medical Equipment & Technology Stocks for Monday, May 13
Discover the top 4 undervalued Advanced Medical Equipment & Technology stocks for Monday, May 13 based on AAII’s Stock Grades.Jenna Brashear
3 Undervalued Advanced Medical Equipment & Technology Stocks for Thursday, June 15
Discover the top 3 undervalued Advanced Medical Equipment & Technology stocks for Thursday, June 15 based on AAII’s Stock Grades.Eunice Kim
Financial Summary
| Share Statistics | AEMD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $4.1 | $437.4 | 4% |
|
| Shares Out (Mil) | 0.4 | 40.7 | 2% |
|
| Institutional Ownership | 93.2% | 83.6% | 63% |
|
| Float (Mil) | 0.7 | 35.5 | 2% |
|
| Beta | 1.40 | 0.85 | 79% |
|
| Avg Daily Volume (000s) | 65 | 333 | 32% |
|
| Price Change (52-week) |
(76.6%) | 68.1% | 10% |
|
| Growth | AEMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | 1.8% | (5.7%) | 42% |
|
| EPS (5yr) | na | 10.6% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (15.6%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 1 | |
| Current EPS | ($2.905) | ($5.735) | ($0.570) | |
| Month Ago EPS | ($2.905) | ($5.735) | ($0.570) | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | ($4.050) | ($16.150) | ($2.500) | |
| Year/Year Chg | (27.8%) | (89.2%) | (98.7%) | |
| Financials | AEMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $141 | na |
|
| Net Income (TTM) (Mil) | ($7) | ($9) | 32% |
|
| EPS (TTM) | ($31.451) | ($0.400) | 2% |
|
| Operating Cash Flow (TTM) (Mil) | ($7) | ($1) | 23% |
|
| Net Cash Flow (TTM) (Mil) | na | $1 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $27 | 0% |
|
| Enterprise Value (Q1) (Mil) | $0 | $381 | 4% |
|
| Valuation | AEMD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.53 | 2.62 | 11% |
|
| P/E | na | 30.0 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | AEMD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 59.0% | na |
|
| Net Margin | na | (6.6%) | na |
|
| ROA | (120.2%) | (11.3%) | 4% |
|
| ROE | (160.9%) | (10.1%) | 5% |
|
| Liabilities to Assets | 16.6% | 47.1% | 11% |
|
| F-Score | 3 | 4 | 18% |
|
Aethlon Medical, Inc. did not pass any screens on 11/4/2026.
